Invention Grant
- Patent Title: Monoclonal antibodies against c-Met
-
Application No.: US16548883Application Date: 2019-08-23
-
Publication No.: US11512140B2Publication Date: 2022-11-29
- Inventor: Joost J. Neijssen , Bart De Goeij , Edward Norbert Van Den Brink , Aran Frank Labrijn , Rene Hoet , Janine Schuurman , Paul Parren , Jan Van De Winkel
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Main IPC: C07K16/30
- IPC: C07K16/30 ; G01N33/574 ; A61P35/00 ; A61K39/395 ; C07K16/28 ; A61K45/06 ; C07K16/40 ; A61K39/00
Abstract:
Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Public/Granted literature
- US20200079872A1 MONOCLONAL ANTIBODIES AGAINST C-MET Public/Granted day:2020-03-12
Information query
